Nashville Biosciences will offer access to BioVU, Vanderbilt University Medical Center's collection of DNA samples and patient records, through BC Platforms' solution.
The approach allows scientists to look at single amino acid variants linked to diseases like cancer and could aid the investigation of tumor heterogeneity.
A Georgia Tech team found that the reliance of genome-wide association studies on European populations has skewed estimates of disease risk in other populations.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.
A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.
While next-generation sequencing (NGS) has driven recent advances in precision oncology research, it often falls short when identifying the molecular mechanisms underlying many malignancies. As a result, alternative NGS-based approaches are needed to identify oncogenic drivers and potential drug targets.
Rhythm Pharmaceuticals and Genomenon will discuss their efforts to assemble a database of mutations associated with rare genetic disorders of obesity, and how this was optimized to facilitate a deep understanding of the variant landscape of melanocortin-4 receptor (MC4R)-pathway genes. This database may help identify MC4R-pathway deficient individuals who might benefit from future precision therapies.
